Weight-adjusted dosing of tinzaparin for thromboprophylaxis in obese medical patients

BACKGROUND: The optimal dose of tinzaparin for prophylaxis in obese medical patients is not well defined. OBJECTIVES: To evaluate the anti-Xa activity in obese medical patients on tinzaparin prophylaxis adjusted for actual bodyweight. METHODS: Patients with a body mass index of ≥30 kg/m(2) treated w...

Descripción completa

Detalles Bibliográficos
Autores principales: Pfrepper, Christian, Koch, Elisabeth, Weise, Maria, Siegemund, Roland, Siegemund, Annelie, Petros, Sirak, Metze, Michael
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Elsevier 2023
Materias:
Original Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9975291/
https://www.ncbi.nlm.nih.gov/pubmed/36876282
http://dx.doi.org/10.1016/j.rpth.2023.100054

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9975291/
https://www.ncbi.nlm.nih.gov/pubmed/36876282
http://dx.doi.org/10.1016/j.rpth.2023.100054

Ejemplares similares